Inovio Pharmaceuticals Inc vs PayPal Holdings, Inc. — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while PayPal Holdings, Inc. trades at $57.99 (market cap $50.47B). The key difference: PayPal Holdings, Inc. is far larger — about 642.5× Inovio Pharmaceuticals Inc's market cap, and PayPal Holdings, Inc. pays a 0.95% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | PYPL | |
|---|---|---|
Market Cap | $78.55M | $50.47B |
Sector | Health | Financials |
52-Week High | $2.87 | $76.13 |
52-Week Low | $0.66 | $39.08 |
Enterprise Value | $49.56M | $52.62B |
Dividend Yield | — | 0.95% |
Trailing returns across standard periods
Latest headlines on both assets
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants. The Company offers online payment solutions. PayPal Holdings serves customers worldwide.
Read more on PYPL →